ASX - Delayed Quote AUD

PharmX Technologies Limited (PHX.AX)

0.0920
+0.0030
+(3.37%)
At close: 3:13:28 PM GMT+10
Loading Chart for PHX.AX
  • Previous Close 0.0890
  • Open 0.0890
  • Bid 0.0880 x --
  • Ask 0.0950 x --
  • Day's Range 0.0860 - 0.0920
  • 52 Week Range 0.0270 - 0.0920
  • Volume 321,731
  • Avg. Volume 459,266
  • Market Cap (intraday) 55.063M
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date Aug 19, 2025 - Aug 25, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Nov 28, 2023
  • 1y Target Est --

PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering gateway; PharmX Marketplace, an online sales and marketing platform; and PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023. PharmX Technologies Limited was incorporated in 1950 and is headquartered in Sydney, Australia.

pharmx.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PHX.AX

View More

Performance Overview: PHX.AX

Trailing total returns as of 6/5/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

PHX.AX
24.32%
S&P/ASX 200 [XJO] (^AXJO)
4.65%

1-Year Return

PHX.AX
206.67%
S&P/ASX 200 [XJO] (^AXJO)
9.91%

3-Year Return

PHX.AX
152.62%
S&P/ASX 200 [XJO] (^AXJO)
17.96%

5-Year Return

PHX.AX
104.59%
S&P/ASX 200 [XJO] (^AXJO)
42.35%

Compare To: PHX.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PHX.AX

View More

Valuation Measures

Annual
As of 6/4/2025
  • Market Cap

    53.27M

  • Enterprise Value

    48.97M

  • Trailing P/E

    1.39k

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.61

  • Price/Book (mrq)

    3.30

  • Enterprise Value/Revenue

    7.00

  • Enterprise Value/EBITDA

    33.18

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.37%

  • Return on Assets (ttm)

    0.55%

  • Return on Equity (ttm)

    0.09%

  • Revenue (ttm)

    8.63M

  • Net Income Avi to Common (ttm)

    14k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.48M

  • Total Debt/Equity (mrq)

    1.16%

  • Levered Free Cash Flow (ttm)

    -8.34M

Research Analysis: PHX.AX

View More

Company Insights: PHX.AX

Research Reports: PHX.AX

View More

People Also Watch